Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3763911017 | Aspirin 500 mg and glycine 133 mg orodispersible tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3763912012 | Product containing precisely aspirin 500 milligram and glycine 133 milligram/1 each conventional release orodispersible tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely aspirin 500 milligram and glycine 133 milligram/1 each conventional release orodispersible tablet (clinical drug) | Is a | Aspirin compound preparation | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aspirin 500 milligram and glycine 133 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has active ingredient | Aspirin | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aspirin 500 milligram and glycine 133 milligram/1 each conventional release orodispersible tablet (clinical drug) | Is a | Product containing aspirin and glycine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aspirin 500 milligram and glycine 133 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has active ingredient | Glycine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aspirin 500 milligram and glycine 133 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aspirin 500 milligram and glycine 133 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aspirin 500 milligram and glycine 133 milligram/1 each conventional release orodispersible tablet (clinical drug) | Is a | Product containing aspirin in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aspirin 500 milligram and glycine 133 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has manufactured dose form | Dispersible tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aspirin 500 milligram and glycine 133 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has manufactured dose form | Dispersible tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aspirin 500 milligram and glycine 133 milligram/1 each conventional release orodispersible tablet (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aspirin 500 milligram and glycine 133 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aspirin 500 milligram and glycine 133 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely aspirin 500 milligram and glycine 133 milligram/1 each conventional release orodispersible tablet (clinical drug) | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aspirin 500 milligram and glycine 133 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely aspirin 500 milligram and glycine 133 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely aspirin 500 milligram and glycine 133 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has manufactured dose form | Conventional release orodispersible tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aspirin 500 milligram and glycine 133 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely aspirin 500 milligram and glycine 133 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely aspirin 500 milligram and glycine 133 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely aspirin 500 milligram and glycine 133 milligram/1 each conventional release orodispersible tablet (clinical drug) | Is a | Product containing only aspirin and glycine in oromucosal dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aspirin 500 milligram and glycine 133 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength numerator value | 500 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely aspirin 500 milligram and glycine 133 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has precise active ingredient | Glycine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely aspirin 500 milligram and glycine 133 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has precise active ingredient | Aspirin | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely aspirin 500 milligram and glycine 133 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength numerator value | 133 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely aspirin 500 milligram and glycine 133 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has basis of strength substance | Aspirin | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely aspirin 500 milligram and glycine 133 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has basis of strength substance | Glycine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely aspirin 500 milligram and glycine 133 milligram/1 each conventional release orodispersible tablet (clinical drug) | Is a | Product containing only aspirin and glycine (medicinal product) | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Aspirin+glycine 500mg/133mg dispersible tablet - product | Is a | False | Product containing precisely aspirin 500 milligram and glycine 133 milligram/1 each conventional release orodispersible tablet (clinical drug) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR